MARIGOLD Study: A Study of RO4917523 Versus Placebo as Adjunctive Therapy in Patients With Major Depressive Disorder and an Inadequate Response to Ongoing Antidepressant Therapy
Open the official record
This page only displays public information reproduced from the official ClinicalTrials.gov record NCT01437657. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Parallel-group Study of the Safety and Efficacy of RO4917523 Versus Placebo, as Adjunctive Therapy in Patients With Major Depressive Disorder With Inadequate Response to Ongoing Antidepressant Treatment
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, double-blind, placebo-controlled, parallel group study will evaluate the safety and efficacy of RO4917523 as adjunctive therapy in patients with major depressive disorder and an inadequate response to ongoing antidepressant therapy. Anticipated time on study treatment is 6 weeks with a 3-week follow-up.
Study identification
- NCT ID
- NCT01437657
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 319 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 70 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2011 (Type not available)
- Primary completion
- Sep 2013 (Actual)
- Completion
- Sep 2013 (Actual)
- Last update posted
- Nov 2, 2016
2011 – 2013
United States locations
- U.S. sites
- 28
- U.S. states
- 13
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Little Rock | Arkansas | 72223 | — |
| Not listed | Costa Mesa | California | 92626 | — |
| Not listed | Garden Grove | California | 92845 | — |
| Not listed | Oceanside | California | 92056 | — |
| Not listed | Orange | California | 92868 | — |
| Not listed | Riverside | California | 92506 | — |
| Not listed | San Diego | California | 92102 | — |
| Not listed | San Diego | California | 92103 | — |
| Not listed | San Diego | California | 92121 | — |
| Not listed | Santa Ana | California | 92705 | — |
| Not listed | Wildomar | California | 92595 | — |
| Not listed | Atlanta | Georgia | 30328 | — |
| Not listed | Libertyville | Illinois | 60048 | — |
| Not listed | Naperville | Illinois | 60563 | — |
| Not listed | Oak Brook | Illinois | 60523 | — |
| Not listed | Shreveport | Louisiana | 71115 | — |
| Not listed | Baltimore | Maryland | 21285 | — |
| Not listed | Las Vegas | Nevada | 89102 | — |
| Not listed | Marlton | New Jersey | 08053 | — |
| Not listed | Brooklyn | New York | 11201 | — |
| Not listed | Cedarhurst | New York | 11516 | — |
| Not listed | Oklahoma City | Oklahoma | 73112 | — |
| Not listed | Norristown | Pennsylvania | 19403 | — |
| Not listed | Philadelphia | Pennsylvania | 19104 | — |
| Not listed | Philadelphia | Pennsylvania | 19139 | — |
| Not listed | Pittsburgh | Pennsylvania | 15213 | — |
| Not listed | Memphis | Tennessee | 38119 | — |
| Not listed | Kirkland | Washington | 98033 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 48 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01437657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 2, 2016 · Synced Nov 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.